RK
Ravi Kumar Soni
About Ravi Kumar Soni
Data last updated:
Ravi Kumar Soni is a Director at Suryaanjan Pharmaceuticals India Private Limited (since 2020). The company operates in Chemicals. Suryaanjan Pharmaceuticals India Private Limited reported revenue of ₹48 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Suryaanjan Pharmaceuticals India Private Limited U24231RJ2020PTC069704 | Director | 19 Jul 2020 | 2020 | ₹48 Lakh (FY 2024) | Active |
Board colleagues of Ravi Kumar Soni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjana Soni | 08799905 | Suryaanjan Pharmaceuticals India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kumar Soni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kumar Soni
Ravi Kumar Soni currently holds 1 directorship: Suryaanjan Pharmaceuticals India Private Limited (Director, since 19 Jul 2020, revenue ₹48 Lakh (FY 2024)).
Ravi Kumar Soni was first appointed on 19 Jul 2020 as Director at Suryaanjan Pharmaceuticals India Private Limited.
The current boards of Ravi Kumar Soni's companies include Anjana Soni (Suryaanjan Pharmaceuticals India Private Limited).